Table 3

Predictors of two types of AMD by multivariate analysis

OutcomeEffectDiabetes vs. nondiabetesDiabetes w/ DR vs. diabetes w/o DRPDR vs. NPDR
HR (99% CI)P valueHR (99% CI)P valueHR (99% CI)P value
Nonexudative AMDGroup1.23 (0.88–1.70)0.1083.89 (1.35–11.23)0.0010.53 (0.12–2.36)0.277
Sex (ref.: female)1.34 (0.98–1.82)0.0151.45 (0.70–3.01)0.1890.78 (0.21–2.90)0.624
CCI total1.27 (1.20–1.34)<0.0011.08 (0.90–1.31)0.2820.81 (0.52–1.27)0.234
Hypertension1.15 (0.83–1.60)0.2771.16 (0.45–2.97)0.6931.31 (0.32–5.28)0.621
Hyperlipidemia1.19 (0.80–1.78)0.2650.72 (0.34–1.52)0.2531.17 (0.30–4.50)0.766
Exudative AMDGroup1.37 (0.96–1.97)0.0233.42 (1.48–7.90)<0.0012.27 (0.74–6.92)0.058
Sex (ref.: female)1.65 (1.19–2.30)<0.0012.05 (1.06–3.99)0.0052.54 (0.82–7.92)0.034
CCI total1.23 (1.13–1.35)<0.0011.06 (0.92–1.22)0.3181.00 (0.81–1.24)0.975
Hypertension0.99 (0.68–1.43)0.9190.83 (0.39–1.77)0.5190.87 (0.26–2.88)0.761
Hyperlipidemia1.12 (0.72–1.75)0.5121.30 (0.70–2.40)0.2751.06 (0.36–3.08)0.898
  • Groups: Diabetes vs. nondiabetes: diabetes (reference: nondiabetes); diabetes w/DR vs. diabetes w/o DR: diabetes w/DR (reference: diabetes w/o DR); PDR vs. NPDR: PDR (reference: NPDR). w/, with; w/o, without.